Abstract
We aimed to compare the local control rates between miriplatin and epirubicin in lipiodol-based transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Patients who underwent targeted TACE using miriplatin (47 patients, 66 lesions) or epirubicin (64 patients, 79 lesions) as the sole therapy were enrolled. The local control rates were compared using the Kaplan-Meier estimator with the log-rank test. The patient and tumor parameters were subjected to univariate and multivariate analyses using the Cox proportional hazards model. The overall local recurrence rates were 39.3% and 31.6% for the miriplatin and epirubicin groups, respectively. The local control rate was significantly higher in the epirubicin group than in the miriplatin group (P < 0.001). The local control rates at 6 months and 1 year were 70.7% and 44.8% for the miriplatin group and 83.4% and 69.2% for the epirubicin group, respectively. Multivariate analysis showed that the serum α-fetoprotein level ≥ 20 ng/mL (hazard ratio 2.96; P < 0.001), miriplatin usage (hazard ratio 2.53; P = 0.002), and Child-Pugh class B (hazard ratio 1.89; P = 0.042) affected local progression. Lipiodol-based targeted TACE using miriplatin had inferior local control rates ...Continue Reading
References
Oct 15, 1989·Cancer·J ShibataM Nakano
Mar 1, 1989·Radiology·H NakamuraS Sawada
Mar 1, 1995·Cardiovascular and Interventional Radiology·T HashimotoC Kuroda
Feb 24, 2001·American Journal of Clinical Oncology·Y OnoY Nishimura
Feb 27, 2001·AJR. American Journal of Roentgenology·K TakayasuH Ueno
Jul 2, 2002·Radiology·Calogero CammàMario Cottone
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Jan 24, 2004·Investigational New Drugs·Takuji OkusakaYasuhiko Kubo
Mar 23, 2007·Journal of Vascular and Interventional Radiology : JVIR·Shiro MiyayamaTakeshi Mitsui
Nov 29, 2008·Cancer Science·Mitsuharu HanadaTakashi Yamaoka
Dec 24, 2008·Cancer Chemotherapy and Pharmacology·Mitsuharu HanadaFumio Nishikaku
Jul 14, 2010·Journal of Vascular and Interventional Radiology : JVIR·Tomokazu KawaokaKazuaki Chayama
Jan 13, 2011·World Journal of Radiology·Jin IwazawaTakashi Mitani
Jun 29, 2011·Oncology·Norihiro ImaiHiromitsu Kumada
Jan 10, 2012·Japanese Journal of Radiology·Shiro MiyayamaOsamu Matsui
Citations
Oct 3, 2014·BioMed Research International·Daisuke YasuiShin-ichiro Kumita
Dec 25, 2012·Journal of Vascular and Interventional Radiology : JVIR·Nicholas J PetruzziDaniel B Brown
Apr 5, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Jin IwazawaTakashi Mitani
Aug 21, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takahiro HandaSatoshi Mochida
Jun 26, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kentarou OtsujiHisataka Moriwaki
Jan 9, 2016·Experimental Biology and Medicine·Ying ZhangYong Sun
Jun 29, 2017·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kousuke KubotaWasaburo Koizumi
Jan 12, 2016·PloS One·Toru IshikawaToshiaki Yoshida
Oct 14, 2014·World Journal of Gastroenterology : WJG·Satoru MurataShin-ichiro Kumita
Aug 7, 2020·PloS One·Daisuke YasuiShin-Ichiro Kumita
Jan 8, 2021·Journal of Hepatocellular Carcinoma·Chen ZhouBin Xiong
Jul 28, 2021·Cardiovascular and Interventional Radiology·Seungchul HanWon Chang